| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/26/2013 | CN103172562A Trisubstituted amine compounds as inhibitors of cholesteryl ester transfer protein CETP |
| 06/26/2013 | CN103172540A Phenylglycine histone deacetylase inhibitor as well as preparation method and applications thereof |
| 06/26/2013 | CN103172512A Cajanin compound with similar structures, as well as preparation method and application thereof |
| 06/26/2013 | CN103169952A Glucose sensitive film for performing controlled release of insulin |
| 06/26/2013 | CN103169946A Application of Safenour cyclopeptide in oral insulin medicine for treating diabetes |
| 06/26/2013 | CN103169944A Compound earthworm protein preparation for assistant adjustment of blood fat |
| 06/26/2013 | CN103169895A Traditional Chinese medicine used for losing weight |
| 06/26/2013 | CN103169893A Compound blood sugar reducing preparation and its preparation method |
| 06/26/2013 | CN103169884A Blood glucose reducing composition, medicine or health-care product containing blood glucose reducing composition |
| 06/26/2013 | CN103169882A Traditional Chinese medicine composition for treating diabetes |
| 06/26/2013 | CN103169868A Oral medicine astragalus mongholicus capsule with function of quenching thirst for treating diabetes mellitus and preparation method thereof |
| 06/26/2013 | CN103169865A Traditional Chinese medicine oral syrup for treating diabetes (diabetes mellitus) |
| 06/26/2013 | CN103169854A Drug composition for treating diabetes mellitus and complication thereof |
| 06/26/2013 | CN103169815A Radix tetrastigme lozenge and preparation method thereof |
| 06/26/2013 | CN103169793A Medicine for treating hypertension, hyperlipoidemia and diabetes mellitus |
| 06/26/2013 | CN103169777A Traditional Chinese medicine capsule for treating cardiovascular disease |
| 06/26/2013 | CN103169771A Method for extracting maslinic acid and oleanolic acid containing mixture from olea europaea L. pomace |
| 06/26/2013 | CN103169765A Eucommia ulmoides seed oil and red rice compound soft capsule preparation and preparation method thereof |
| 06/26/2013 | CN103169756A Pharmaceutical composition of water-soluble vitamins for injection, fat-soluble vitamin injection and fat emulsion injection |
| 06/26/2013 | CN103169755A Pharmaceutical composition of water-soluble vitamins for injection, fat-soluble vitamins for injection and fat emulsion injection |
| 06/26/2013 | CN103169751A Extracting process for optimizing alpha-glucosidase inhibitor in nanometer dogwood by response surface method |
| 06/26/2013 | CN103169750A Ultrasonic extraction method for extracting flavone from dianthus superbus |
| 06/26/2013 | CN103169743A Mango leaf extractive as well as preparation method and application thereof |
| 06/26/2013 | CN103169719A Application of anthracene nucleus antibiotic and its pharmaceutical salt for treating diabetic eye diseases |
| 06/26/2013 | CN103169711A Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making same |
| 06/26/2013 | CN103169707A New medical application of lauric acid monoglyceride |
| 06/26/2013 | CN103169704A Compound slow-release capsule preparation of nicotinic acid and simvastatin as well as preparation method of preparation |
| 06/26/2013 | CN103169682A Polysaccharide sulfate tablet and preparation method of polysaccharide sulfate tablet |
| 06/26/2013 | CN103169669A Agomelatine covered pellet and drug composition capable of being dispersed in mouth |
| 06/26/2013 | CN103169666A Preparation method and application of halide phenolic compound solid dispersion |
| 06/26/2013 | CN103169092A L-asparaginic acid chelated calcium drinking water |
| 06/26/2013 | CN103169075A Fermented bean product fermented by lactobacillus plantarum ST-III and alpha-glucosidase inhibitor |
| 06/26/2013 | CN103168995A Health-care food for preventing diabetics |
| 06/26/2013 | CN103168983A High-activity multi-nutrition active polypeptide for enhancing immunity |
| 06/26/2013 | CN103168882A Health-care tea beneficial to reducing blood glucose and slowing down diabetic complications |
| 06/26/2013 | CN102552688B Healthcare product for treating hyperlipidemia and preparation method thereof |
| 06/26/2013 | CN102349881B Levocarnitine thin film coated tablets and preparation method thereof |
| 06/26/2013 | CN102293796B Active part of lysimachia trientaloides Hemsl., and extraction method and application of active part |
| 06/26/2013 | CN102286054B Cyclovirobuxinum D derivatives and preparation method and use thereof |
| 06/26/2013 | CN102250019B (Thio) barbituric acid compound and application thereof |
| 06/26/2013 | CN102160862B Antiobesity agent and pharmaceutical, food, or cosmetic provided with fat accumulation inhibiting effect |
| 06/26/2013 | CN102153630B Ring octapeptide and preparation method and application thereof in medicament making |
| 06/26/2013 | CN101983073B Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation |
| 06/26/2013 | CN101863872B Method for extracting PiPerlonguminine and drug combination comprising same |
| 06/26/2013 | CN101674821B Composition for treating diabetes and metabolic disorders with quercetin, myrcetin and chlorogenic acid |
| 06/26/2013 | CN101426780B Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 06/25/2013 | US8470808 Oxidant scavengers for treatment of type I diabetes or type II diabetes |
| 06/25/2013 | US8470773 Thiophenes as glucagon receptor antagonists, compositions, and methods for their use |
| 06/25/2013 | US8470317 B7RP-1 antagonists |
| 06/25/2013 | US8470301 Particulate materials |
| 06/25/2013 | CA2724774C Pyrazolospiroketone acetyl-coa carboxylase inhibitors |
| 06/25/2013 | CA2633074C Elongase genes and uses thereof |
| 06/25/2013 | CA2598988C Cyclohepta[b]pyridine-3-carbonylguanidine derivative and pharmaceutical product containing the same as nhe inhibitors |
| 06/25/2013 | CA2591912C Pyrimidinylisoxazole derivatives |
| 06/25/2013 | CA2588963C 1-substituted-3-.beta.-d-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same |
| 06/25/2013 | CA2576850C Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 06/25/2013 | CA2551611C Thiazole derivatives for treating or preventing parkinson's disease |
| 06/25/2013 | CA2482464C Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease |
| 06/25/2013 | CA2407808C Cyclipostins, process for their preparation and use thereof |
| 06/20/2013 | WO2013090550A1 Novel glycoside compounds |
| 06/20/2013 | WO2013090454A2 Novel glp-1 receptor modulators |
| 06/20/2013 | WO2013089429A1 Composition for preventing or treating hyperlipidemia containing water extract of pleurotus eryngii var. ferulae as active ingredient |
| 06/20/2013 | WO2013089402A1 Composition comprising gypenoside extract of gynostemma pentaphyllum (thunb.) makino for treating or preventing type ιι diabetes, obesity, or hyperlipidemia |
| 06/20/2013 | WO2013089252A1 Modification of helper t cell-inducing polypeptide |
| 06/20/2013 | WO2013089157A1 Oligonucleotide and therapeutic agent for hyperlipidemia containing same as active ingredient |
| 06/20/2013 | WO2013088241A1 Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin |
| 06/20/2013 | WO2013087643A1 1,3,5 -triazine-2-amine derivatives, preparation thereof and diagnostic and therapeutic use thereof |
| 06/20/2013 | WO2013087023A1 Natural weight reduction health composition and application thereof |
| 06/20/2013 | WO2013086980A1 Sulfonylurea guanidine, preparation method and use thereof |
| 06/20/2013 | WO2013086786A1 Compound and composition having hypoglycemic effect and use thereof |
| 06/20/2013 | WO2013086785A1 Compound and composition having hypoglycemic effect and use thereof |
| 06/20/2013 | WO2013062294A3 Improved preparation method for mitiglinide calcium |
| 06/20/2013 | WO2013050529A3 Use of igf-1 in the stimulation of treg cell activity and the treatment autoimmune disorders |
| 06/20/2013 | WO2013032744A3 Compositions and methods for increasing desirable microbiota |
| 06/20/2013 | US20130158234 Specific binding agents of human angiopoietin-2 |
| 06/20/2013 | US20130157943 Method and use of peptide antagonists of zonolin to prevent or delay the onset of diabetes |
| 06/20/2013 | US20130156712 Stable surfactant compositions for suspending components |
| 06/20/2013 | US20130156696 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 06/20/2013 | DE102006044448B4 Gelartiges Basenpräparat zur Supplementierung von Spurenelementen und Verfahren zu dessen Herstellung Gel-base preparation for supplementation of trace elements and process for its production |
| 06/20/2013 | CA2857276A1 Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin |
| 06/20/2013 | CA2857197A1 Novel glp-1 receptor modulators |
| 06/19/2013 | EP2604689A1 Anti-obesity agent and anti-obesity food |
| 06/19/2013 | EP2604685A1 Method of producing pancreatic hormone-producing cells |
| 06/19/2013 | EP2604612A1 C-aryl glucoside derivatives, preparation rpocess and pharmaceutical use thereof |
| 06/19/2013 | EP2604604A1 Benzofuranyl derivatives used as glucokinase inhibitors |
| 06/19/2013 | EP2604591A1 Process for preparing aminoadamantyl carbamate derivatives |
| 06/19/2013 | EP2604272A1 Effective fraction from the fruiting bodies of ganoderma lucidum, extraction method, use and preparation thereof |
| 06/19/2013 | EP2604254A1 Slimming composition |
| 06/19/2013 | EP2603510A1 New azacyclic compounds |
| 06/19/2013 | EP2603502A1 4 - aminoquinazolin- 2 - yl - 1 - pyrrazole - 4 - carboxylic acid compounds as prolyl hydroxylase inhibitors |
| 06/19/2013 | EP2603496A1 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds |
| 06/19/2013 | EP2603226A2 Treatment of diabetes with pancreatic endocrine precursor cells |
| 06/19/2013 | EP2603211A1 Composition for treating hyperlipidemia |
| 06/19/2013 | CN103168036A Soft cationic mitochondrial uncouplers |
| 06/19/2013 | CN103168031A Tetrahydroquinoline derivatives used as AMPK activators |
| 06/19/2013 | CN103168028A Cyclic amide derivative |
| 06/19/2013 | CN103167878A Treating diabetes melitus using insulin injections administered with varying injection intervals |
| 06/19/2013 | CN103160557A Purpose of ribosomal protein S5 in catalyzing of protein molecules for generatation of dephosphorylation reaction |
| 06/19/2013 | CN103159788A Condensed imidazole formamide serving as transient receptor potential vanillin 3 (TRPV3) modifier |
| 06/19/2013 | CN103159760A Azaindole derivatives as cftr modulators |